The global E-Pharmacy Market is experiencing significant growth, driven by the increasing adoption of digital platforms for pharmaceutical services, the convenience of online medication procurement, and the growing demand for efficient healthcare solutions.
The All India Organisation of Chemists and Druggists (AIOCD) has urged pharmaceutical companies to avoid advertising their products on e-pharmacy platforms, alleging that these platforms operate illegally. In a letter dated November 23, AIOCD stated that certain e-pharmacy platforms violate the Drugs & Cosmetics Act, 1940, and Rules of 1945, defying principles outlined in the Act.
Tata Digital: The company reported a 160% jump in operating revenue to Rs 1,627 crore for the fiscal year ended 2023. However, its net loss more than doubled from the previous year to Rs 1,254.9 crore, according to its recent regulatory filings for the financial year under review.
Internet pharmacies account for 3 per cent of total retail sales in India - double that of China - despite the erratic regulations and unfavourable growth conditions. Denying the demand and booming industry would end up creating a black market